02616.HK 财务： CStone Pharmaceuticals AI 分析

Q: 技术分析指标如何适用于 02616.HK？

根据技术分析，CStone Pharmaceuticals 的综合信号为 Buy。CStone Pharmaceuticals 有 4 个买入信号，2 个中性信号和 1 个卖出信号。

Q: 02616.HK 的斐波那契回调水平是多少？

CStone Pharmaceuticals 的斐波那契回调水平是 高于0%水平。

Q: CStone Pharmaceuticals 的 RSI 是多少？

CStone Pharmaceuticals 的 RSI 目前为 61.42，表明处于 中立 状态

Q: CStone Pharmaceuticals 接下来 12 个月的价格是多少？

CStone Pharmaceuticals 02616.HK 接下来 12 个月的价格预计为 $0。

Q: CStone Pharmaceuticals 预计会涨到多高？

据华尔街分析师称，CStone Pharmaceuticals 预计将达到 $0 的高预测值。

主页

股票

02616.HK

预测

CSTONE PHARMA-B (02616.HK)

CStone Pharmaceuticals

HK$6.11

-4.53%

$-0.29

休市： Jan 16, 16:00:00 HKT

关键数据

前收盘价

$6.32

开盘价

$6.4

当日区间

$6.08 - $6.4

52周范围

$2.02 - $13.15

交易量

3.4M

平均成交量

10.9M

每股收益（TTM）

-0.32

股息收益率

市值

$8.9B

什么是 CSTONE PHARMA-B？

Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of pharmaceutical products. The company is headquartered in Suzhou, Jiangsu and currently employs 93 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The firm is also engaged in the development and commercialization of immuno-oncology. The firm primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.

功能特性

交易策略

资源

市场

02616.HK 股价预测摘要

02616.HK stock price ended at $6.12 on 星期五, after dropping 3.16%

On the latest trading day Jan 16, 2026, the stock price of 02616.HK fell by 3.16%, dropping from $6.40 to $6.12. During the session, the stock saw a volatility of 5.26%, with prices oscillating between a daily low of $6.08 and a high of $6.40. On the latest trading day, the trading volume for 02616.HK decreased by 1.2M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 2.8M shares were traded, with a market value of approximately $8.9B.

02616.HK 技术面信号

技术面信号摘要

购买信号 4

中性信号 2

卖出信号 1

Strong Sell

Sell

Neutral

Buy

Strong Buy

02616.HK目前显示4个买入信号和1个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-3.16%。总体而言，技术指标显示中期前景为Buy。

02616.HK 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 02616.HK 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 02616.HK？



02616.HK 的斐波那契回调水平是多少？



CStone Pharmaceuticals 的 RSI 是多少？



CStone Pharmaceuticals 接下来 12 个月的价格是多少？



CStone Pharmaceuticals 预计会涨到多高？



CStone Pharmaceuticals（02616.HK）价格

02616.HK 股价走势图